SIGN-UP NOW! SIGN-UP NOW! Click to become a The VoiceAmerica Talk Member for Free!
voiceamerica-health-and-wellness radio logo
Apple logo Google Play Store Kindle store
C. diff. Spores and More
top banner

C. diff. Spores and More

Tuesday at 10 AM Pacific

April 6th 2021: Camilla Graham MD, Alba Muhlfeld, Erik Dubburke, MD, MSPH

Join Our Guests Camilla Graham MD "Ri-CoDIFy: Ridinilazole’s Phase 3 Trial for the Treatment of C. difficile and Reduction of Recurrence." . Dr.Camilla S. Graham is Vice President and Chief Clinical Information Officer at Summit Therapeutics as well as a staff physician at Beth Israel Deaconess Medical Center in Boston, MA, and on faculty at Harvard Medical School. Guest: Alba Muhlfeld, C. diff. Survivor - Sharing her C. diff. infection journey. Guest: Erik Dubburke, MD, MSPH discusses “Optimizing Prevention of Hospital-Onset Clostridioides difficile infection.” Dr. Erik Dubberke is an A

Read more
Share Email SHARE
Download PDF DOWNLOAD PDF
Get Code GET CODE

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
LISTEN LIVE
EPISODE ON DEMAND
VIEW HOST PAGE
Questions? Comments?
Call In Live!
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guests

Guest Image

Camilla Graham, MD, MPH

Vice President and Chief Clinical Information Officer at Summit Therapeutics as well as a staff physician at Beth Israel Deaconess Medical Center in Boston, MA, and on faculty at Harvard Medical School. For twenty years she has focused on identifying barriers to care and medical, policy, or reimbursement solutions for infectious diseases. At Summit she is identifying ways to improve the support of patients and investigators in Ri-CoDIFy, the global phase 3 studies of ridinilazole for C. difficile treatment, and reduction of recurrence.
Read more
Guest Image

Alba Mulfeld

C. diff. Survivor
Read more
Guest Image

Alba Muhlfeld

Read more
Guest Image

Erik Dubberke, MD, MSPH

Dr. Erik Dubberke is an Associate Professor of Medicine at Washington University School of Medicine in St. Louis, where he has been a faculty member in the Division of Infectious Diseases since 2005. He is an Associate Hospital Epidemiologist at Barnes-Jewish Hospital, Medical Director of Infection Control at Missouri Baptist Medical Center, and is the Director of the Section of Transplant Infectious Diseases at Washington University. He attended medical school at the University of Illinois at Chicago and did his medicine and infectious diseases training at Barnes-Jewish Hospital/Washington University. He received a Master’s of Science in Public Health from St. Louis University. His mai
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
https://www.voiceamerica.com/show/2441/c-diff-spores-and-more 10/04/2021 01:00 10/04/2021 02:00 C. diff. Spores and More https://www.voiceamerica.com/show/2441/c-diff-spores-and-more Join Our Guests Camilla Graham MD "Ri-CoDIFy: Ridinilazole’s Phase 3 Trial for the Treatment of C. difficile and Reduction of Recurrence." . Dr.Camilla S. Graham is Vice President and Chief Clinical Information Officer at Summit Therapeutics as well as a staff physician at Beth Israel Deaconess Medical Center in Boston, MA, and on faculty at Harvard Medical School. Guest: Alba Muhlfeld, C. diff. Survivor - Sharing her C. diff. infection journey. Guest: Erik Dubburke, MD, MSPH discusses “Optimizing Prevention of Hospital-Onset Clostridioides difficile infection.” Dr. Erik Dubberke is an Associate Professor of Medicine at Washington University School of Medicine in St. Louis, where he has been a faculty member in the Division of Infectious Diseases since 2005. He is an Associate Hospital Epidemiologist at Barnes-Jewish Hospital, Presentations delivered live during the November 14th, 2020 8th Annual International C. diff. Conference & Health EXPO VoiceAmerica | Talk Radio | Online Talk Radio studio@voiceamerica.com false DD/MM/YYYY Add to Calendar
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
Facebook Twitter Linkedin Social Media
presspass-banner